Brief: Gracell Biotechnologies To Present Data Highlighting Preclinical Efficacy Of Smart Cart™
31/10/2023 13:08
Oct 31 (Reuters) - Gracell Biotechnologies Inc GRCL.O :
* GRACELL BIOTECHNOLOGIES TO PRESENT DATA HIGHLIGHTING
PRECLINICAL
EFFICACY OF SMART CART™ AGAINST SOLID TUMORS AT SOCIETY FOR
IMMUNOTHERAPY OF CANCER (SITC) 38TH ANNUAL MEETING
* GRACELL BIOTECHNOLOGIES INC - SMART CAR-T CELLS
DEMONSTRATED
RESISTANCE TO IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT
* GRACELL BIOTECHNOLOGIES INC - SMART CAR-T CELLS
MAINTAINED
LONG-TERM PROLIFERATION AND CYTOTOXICITY BOTH IN VITRO AND IN
VIVO
Source text for Eikon: ID:nGNX1nnMfv
Further company coverage: GRCL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gracell Biotechnologies
See all newsBrief: Gracell Biotechnologies Announces Shareholders’ Approval Of Merger Agreement
Brief: Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma
Newscasts - UK Day Ahead: European shares start last week of 2023 on strong footing
Live Markets: European futures rise after holiday break
Press Digest: British Business - Dec 27